Lexicon Pharmaceuticals (LXRX) Prepaid Assets (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) posted quarterly Prepaid Assets of $3.3 million for Q1 2026, little changed year-over-year from $3.3 million in Q1 2025, and up 10.63% quarter-over-quarter from $3.0 million in Q4 2025.
Lexicon Pharmaceuticals (LXRX) Prepaid Assets (2010 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has reported Prepaid Assets for 17 consecutive years, with $3.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets changed 0.0% year-over-year to $3.3 million; the TTM figure through Mar 2026 stood at $3.3 million (changed 0.0% YoY), while the FY2025 annual figure was $3.0 million, down 33.8% from the prior year.
- Prepaid Assets rose to $3.3 million in Q1 2026 per LXRX's latest filing, from $3.0 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $7.7 million in Q2 2024 and bottomed at $1.9 million in Q1 2022.
- Historically, Prepaid Assets has averaged $4.3 million across 5 years, with a median of $3.7 million in 2025.
- Annual changes were most pronounced in 2023 — Prepaid Assets surged 111.46% — and 2025, when it tumbled 52.65%.
- Lexicon Pharmaceuticals' Prepaid Assets stood at $2.5 million in 2022, then surged by 106.77% to $5.1 million in 2023, then slipped by 11.66% to $4.5 million in 2024, then sank by 33.8% to $3.0 million in 2025, then gained by 10.63% to $3.3 million in 2026.
- Business Quant data shows LXRX's Prepaid Assets at $3.3 million in Q1 2026, $3.0 million in Q4 2025, and $4.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Lexicon Pharmaceuticals | 1.04 Bn | 846.13 Mn | 653,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.13 Mn |
| Mar 31, 2026 | 3.32 Mn |
| Dec 31, 2025 | 3.00 Mn |
| Sep 30, 2025 | 4.09 Mn |
| Jun 30, 2025 | 3.73 Mn |
| Mar 31, 2025 | 3.32 Mn |
| Dec 31, 2024 | 4.53 Mn |
| Sep 30, 2024 | 6.71 Mn |
| Jun 30, 2024 | 7.68 Mn |
| Mar 31, 2024 | 7.01 Mn |
| Dec 31, 2023 | 5.13 Mn |
| Sep 30, 2023 | 4.29 Mn |
| Jun 30, 2023 | 6.12 Mn |
| Mar 31, 2023 | 3.35 Mn |
| Dec 31, 2022 | 2.48 Mn |
| Sep 30, 2022 | 2.82 Mn |
| Jun 30, 2022 | 2.90 Mn |
| Mar 31, 2022 | 1.89 Mn |
| Dec 31, 2021 | 2.16 Mn |
| Sep 30, 2021 | 3.06 Mn |